Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. 

Biotechnology

Systems Oncology

Spyro Mousses

Katy Marhenke

Robert G. Petit II

Lizette Castano

Marvin O’Ketch

Andrew Matricaria

Gavin Bogle

David Azorsa

David Lee

Jeff Kiefer

Daniel D. Von Hoff

The founding team at Systems Oncology has a history of experience with companies such as BlueOcean NutraSciences Inc., Magyar, Bogle & O'Hara LLP, and Iovate Health Sciences. They also have a background in education, with degrees from the University of Toronto in Tax, IP, Securities, and Finance.

Founding Team

Board of Directors

Leadership Team

CEO and Executive Team

Founding Team

About

Team members

Other teams at Systems Oncology

Board of Directors

Leadership Team

CEO and Executive Team